LMDXW 0.00 LumiraDx Limited
| Range: | 0.004-0.0053 | Vol Avg: | 0 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.71 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Sep 29 2021 | Empoloyees: | 1210 | ||
| CUSIP: | G5709L117 | CIK: | 0001685428 | ISIN: | KYG5709L1178 | Country: | GB |
| CEO: | Ms. Veronique Ameye EMBA, Esq., M.B.A. | Website: | https://www.lumiradx.com | ||||
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow